Advertisement

Topics

Novel biomarkers for noninvasive diagnosis of NAFLD-related fibrosis

20:00 EDT 15 Apr 2019 | AAAS

(Mary Ann Liebert, Inc./Genetic Engineering News) With an estimated 25% of people worldwide affected by nonalcoholic fatty liver disease (NAFLD), there is a large unmet need for accurate, noninvasive measures to enhance early diagnosis and screening of hepatic fibrosis.

Original Article: Novel biomarkers for noninvasive diagnosis of NAFLD-related fibrosis

NEXT ARTICLE

More From BioPortfolio on "Novel biomarkers for noninvasive diagnosis of NAFLD-related fibrosis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Genetic Engineering
Genetic engineering is the process of manually adding new DNA to an organism. The goal is to add one or more new traits that are not already found in that organism. Examples of genetically engineered (transgenic) organisms currently on the market include...

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...